Clinical trial
Feasibility and Acceptability of Home Use Continuous Glucose Monitors for Type 2 Diabetes Risk Evaluation in Youth
NCT05404711 is registered in ClinicalTrials.gov with Mary Ellen Vajravelu, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility and Acceptability of Home Use Continuous Glucose Monitors for Type 2 Diabetes Risk Evaluation in Youth
- Lead sponsor
- Mary Ellen Vajravelu, MD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 11, 2022
- Completion date
- December 14, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, overweight and obesity, prediabetes